MXDAS Technology Patent Pages on BioPortfolio:

BioPortfolio - Elan Drug Technologies
Our technologies are supported by robust patent estate of over 1700 ... the MXDAS® (MatriX Drug Absorption System) Technology for Acorda Therapeutics. ...
http://www.bioportfolio.com/biocorporate/35301-Elan+Drug+Tec...

Results from other life science and pharmaceutical sites:

Elan Reports Third Quarter 2009 Financial Results - Yahoo! Finance
21 Oct 2009 ... Azactam lost its patent exclusivity in October 2005 and its future sales are ... approved by regulatory authorities using the NanoCrystal® technology. ...
Fampridine-SR incorporates EDT's proprietary MXDAS® (Matrix Drug ...
http://biz.yahoo.com/bw/091021/20091020006940.html?.v=1...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.